{"cluster": 16, "subcluster": 16, "abstract_summ": "ACE inhibitors or angiotensin II (Ang)\u2010type 1 receptor blockers (ARBs), in fact, have been suggested to be avoided as they potentially upregulate ACE2 (1) and, conversely, there are suggestions that ARBs might be beneficial (2) as SARS\u2010CoV\u20102 causing ACE2 downregulation slows the Ang II conversion to the vasodilatory, anti\u2010inflammatory, antioxidant and antiatherosclerotic Ang 1\u20107 (3\u20105), and the use of ARBs by blocking the excessive Ang II type\u20101 receptors activation, would be beneficial upregulating ACE2 activity and increasing Ang 1\u20107 levels.ACEIs and ARBs lead to a reduction in angiotensin II level by increasing the ACE2 level, thus they cause a low cytosolic pH. Increased cardiac ACE2 levels due to ACEIs and ARBs can trigger cardiac arrhythmias and myocarditis by causing the virus to easily enter the heart tissue.Abstract ACE2 being a receptor of entry of SARS-CoV-2 into the host cells, its upregulation has been implicated in increasing susceptibility of individuals to the infections.The most important event is the increased sympathetic activity via the central stimulation, this activity increases pulmonary capillary leaking, causing the ARDS.As the cytosolic pH, which is already low in patients with diabetes will decrease further with the mechanisms mentioned above, the viral load will increase and the infection will be exacerbated.", "title_summ": "Insights from Bartter's and Gitelman's syndromes patientsUrgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemicACE2 and prognosis of COVID\u201019.", "title_abstract_phrases": "ACE inhibitors or angiotensin II (Ang)\u2010type 1 receptor blockers (ARBs), in fact, have been suggested to be avoided as they potentially upregulate ACE2 (1) and, conversely, there are suggestions that ARBs might be beneficial (2) as SARS\u2010CoV\u20102 causing ACE2 downregulation slows the Ang II conversion to the vasodilatory, anti\u2010inflammatory, antioxidant and antiatherosclerotic Ang 1\u20107 (3\u20105), and the use of ARBs by blocking the excessive Ang II type\u20101 receptors activation, would be beneficial upregulating ACE2 activity and increasing Ang 1\u20107 levels.ACEIs and ARBs lead to a reduction in angiotensin II level by increasing the ACE2 level, thus they cause a low cytosolic pH. Increased cardiac ACE2 levels due to ACEIs and ARBs can trigger cardiac arrhythmias and myocarditis by causing the virus to easily enter the heart tissue.Urgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19Abstract ACE2 being a receptor of entry of SARS-CoV-2 into the host cells, its upregulation has been implicated in increasing susceptibility of individuals to the infections.The most important event is the increased sympathetic activity via the central stimulation, this activity increases pulmonary capillary leaking, causing the ARDS.Acute respiratory distress due to interstitial pulmonary fibrosis, cardiomyopathy and shock reported in COVID-19 patients can be explained by imbalanced Angiotensin II and Angiotensin-(1-7) activities."}